| 1 |
other neurological diseases
(300 times)
|
Neurology
(209 times)
|
MS (196 times)
CSF (135 times)
ELISA (22 times)
|
1976 Mixed lymphocyte reaction in multiple sclerosis.
|
| 2 |
ondansetron
(65 times)
|
Neoplasms
(20 times)
|
DEX (6 times)
GRA (5 times)
i.v (5 times)
|
1991 Development of a co-culture system with induced HepG2 cells and K562 cells for examining drug metabolism in vitro. Studies with cyclophosphamide, ondansetron and cisplatin.
|
| 3 |
Operation New Dawn
(35 times)
|
Rehabilitation
(8 times)
|
OIF (32 times)
OEF (31 times)
PTSD (13 times)
|
2011 Sexuality among wounded veterans of Operation Enduring Freedom (OEF), Operation Iraqi Freedom (OIF), and Operation New Dawn (OND): Implications for rehabilitation psychologists.
|
| 4 |
other non-inflammatory neurological diseases
(33 times)
|
Neurology
(22 times)
|
CSF (16 times)
MS (16 times)
IL (7 times)
|
1990 Cerebrospinal fluid interleukin-6 activity in HIV infection and inflammatory and noninflammatory diseases of the nervous system.
|
| 5 |
optic nerve diameter
(27 times)
|
Neurology
(10 times)
|
ONSD (19 times)
TOS (7 times)
ICP (5 times)
|
1998 Echographic measurements of the retrobulbar optic nerve in normal and glaucomatous eyes.
|
| 6 |
oligonucleotide
(15 times)
|
Chemistry Techniques, Analytical
(5 times)
|
SERS (2 times)
ANN (1 time)
CFA (1 time)
|
2005 Cationic niosomes as gene carriers: preparation and cellular uptake in vitro.
|
| 7 |
optic nerve disk
(12 times)
|
Ophthalmology
(8 times)
|
IOP (4 times)
NPG (4 times)
DEC (2 times)
|
1993 Reduction in incidence of optic nerve disease with annual ivermectin to control onchocerciasis.
|
| 8 |
obese non-diabetic
(10 times)
|
Metabolism
(7 times)
|
OD (3 times)
ADRP (1 time)
AT (1 time)
|
2001 Retinoid X receptor expression in skeletal muscle of nondiabetic, obese and type 2 diabetic individuals.
|
| 9 |
ondansetron hydrochloride
(10 times)
|
Neoplasms
(5 times)
|
AG (1 time)
BSA (1 time)
DRG (1 time)
|
1999 Nausea and vomiting induced by arterial chemo-embolization in patients with hepatocellular carcinoma and the antiemetic effect of ondansetron hydrochloride.
|
| 10 |
optic nerve drusen
(10 times)
|
Ophthalmology
(7 times)
|
CNV (3 times)
OCT (2 times)
PDT (2 times)
|
2003 Submacular surgery for choroidal neovascularization secondary to optic nerve drusen.
|
| 11 |
optic nerve decompression
(7 times)
|
Neurosurgical Procedures
(3 times)
|
IIH (3 times)
CVST (1 time)
IOP (1 time)
|
1998 Endoscopic optic nerve decompression: the Graz experience.
|
| 12 |
oxanorbornadiene
(7 times)
|
Biochemistry
(4 times)
|
Ab (1 time)
Boc (1 time)
crDA (1 time)
|
2009 Thiol-selective fluorogenic probes for labeling and release.
|
| 13 |
oxygen nutrient deprivation
(5 times)
|
Brain
(2 times)
|
AKI (1 time)
hAGS (1 time)
hPTECs (1 time)
|
2006 Persistent tolerance to oxygen and nutrient deprivation and N-methyl-D-aspartate in cultured hippocampal slices from hibernating Arctic ground squirrel.
|
| 14 |
Oxanorbornadiene dicarboxylate
(3 times)
|
Chemistry
(2 times)
|
BSA (1 time)
|
2012 Degradable conjugates from oxanorbornadiene reagents.
|
| 15 |
oxidized nanodiamond
(3 times)
|
Chemistry
(2 times)
|
FTIR (2 times)
TGA (2 times)
XRD (2 times)
|
2015 Surface functionalization of nanodiamond with phenylphosphonate.
|
| 16 |
October-November-December
(2 times)
|
Biophysics
(2 times)
|
AMJ (1 time)
AO (1 time)
DTR (1 time)
|
2010 Early-season warning of soybean rust regional epidemics using El Nino Southern/Oscillation information.
|
| 17 |
other neurodevelopmental disorders
(2 times)
|
Pediatrics
(1 time)
|
ASD (2 times)
CA (1 time)
ID (1 time)
|
2014 Adaptive profiles in autism and other neurodevelopmental disorders.
|
| 18 |
other neurological disorder patients
(2 times)
|
Allergy and Immunology
(1 time)
|
CSF (1 time)
IgG (1 time)
MRI (1 time)
|
2006 CSF enrichment of highly differentiated CD8+ T cells in early multiple sclerosis.
|
| 19 |
other neurological disorders or symptoms
(2 times)
|
Neurology
(2 times)
|
CDMS (1 time)
CPMS (1 time)
CSF (1 time)
|
1987 Acute multiple sclerosis exacerbations are characterized by low cerebrospinal fluid suppressor/cytotoxic T-cells.
|
| 20 |
other neuromuscular disorders
(2 times)
|
Communicable Diseases
(1 time)
|
aGAAb (1 time)
aSF (1 time)
CFS (1 time)
|
1994 Studies on enterovirus in patients with chronic fatigue syndrome.
|
| 21 |
other, non-inflammatory disorders
(2 times)
|
Neurology
(2 times)
|
CSF (2 times)
MS (2 times)
ID (1 time)
|
2011 Plasmacytoid dendritic cells are increased in cerebrospinal fluid of untreated patients during multiple sclerosis relapse.
|
| 22 |
oxidized NDs
(2 times)
|
Carbohydrates
(1 time)
|
FTIR (2 times)
ND (2 times)
CS (1 time)
|
2017 Enhanced mechanical properties of chitosan/nanodiamond composites by improving interphase using thermal oxidation of nanodiamond.
|
| 23 |
antagonists--ondansetron
(1 time)
|
Psychopharmacology
(1 time)
|
OXZ (1 time)
WSE (1 time)
|
1998 An anxiolytic-like effect of ondansetron disappears in oxazepam-tolerant rats.
|
| 24 |
non-demyelinating neurological disease
(1 time)
|
Chemistry
(1 time)
|
MS (1 time)
SSPE (1 time)
|
1982 Comparison of two molecular species of ethanolamine plasmalogen in multiple sclerosis and normal myelin.
|
| 25 |
O not determined
(1 time)
|
Veterinary Medicine
(1 time)
|
STEC (1 time)
|
2015 Shiga toxin-producing Escherichia coli O157, O26 and O111 in cattle faeces and hides in Italy.
|
| 26 |
obese non-diabetic participants
(1 time)
|
Endocrinology
(1 time)
|
11beta-HSD (1 time)
D cortisol (1 time)
LND (1 time)
|
2014 Hepatic 11beta-hydroxysteroid dehydrogenase type 1 activity in obesity and type 2 diabetes using a novel triple tracer cortisol technique.
|
| 27 |
occult nodal disease
(1 time)
|
Neoplasms
(1 time)
|
LN (1 time)
NPV (1 time)
|
2022 Pathologic node-negative lung cancer: Adequacy of lymph node yield and a tool to assess the risk of occult nodal disease.
|
| 28 |
oligonucleotide drugs
(1 time)
|
Molecular Biology
(1 time)
|
---
|
2022 Preclinical Safety Assessment of Therapeutic Oligonucleotides.
|
| 29 |
OND and LGNh were significantly lower in the POAG group
(1 time)
|
Ophthalmology
(1 time)
|
Ch (1 time)
LGNh (1 time)
MRI (1 time)
|
2017 MR Imaging of the Anterior Visual Pathway in Primary Open-Angle Glaucoma: Correlation with Octopus 101 Perimetry and Spectralis Optical Coherence Tomography Findings.
|
| 30 |
ondansetron alone
(1 time)
|
Neoplasms
(1 time)
|
ODC (1 time)
|
1993 Ondansetron versus ondansetron, dexamethasone, and chlorpromazine in the prevention of nausea and vomiting associated with multiple-day cisplatin chemotherapy.
|
| 31 |
ondansetron HCl
(1 time)
|
Biomedical Engineering
(1 time)
|
EE (1 time)
i.n (1 time)
SLNs (1 time)
|
2012 Solid lipid nanoparticles of ondansetron HCl for intranasal delivery: development, optimization and evaluation.
|
| 32 |
ondansetron HCl dihydrate
(1 time)
|
Chemistry
(1 time)
|
SR (1 time)
|
2015 Formulation and development of pH-independent/dependent sustained release matrix tablets of ondansetron HCl by a continuous twin-screw melt granulation process.
|
| 33 |
ondansetron hydrochloride dihydrate
(1 time)
|
Chemistry
(1 time)
|
ODF (1 time)
UD (1 time)
|
2018 A novel unit-dose approach for the pharmaceutical compounding of an orodispersible film.
|
| 34 |
open neck dissection
(1 time)
|
|
RARAND (1 time)
RATAND (1 time)
|
2022 Robotic-Assisted Neck Dissection: Our Experience.
|
| 35 |
Ophthalmic Nursing Diploma
(1 time)
|
Nursing
(1 time)
|
RN (1 time)
|
2003 A study of supervised practice from the perspective of the supervisor and the supervised.
|
| 36 |
optic nerve dysfunction
(1 time)
|
Neurology
(1 time)
|
CFPD (1 time)
MS (1 time)
PVER (1 time)
|
1984 Critical frequency of photic driving in the diagnosis of multiple sclerosis.
|
| 37 |
organic neurological diseases
(1 time)
|
Neurology
(1 time)
|
MS (1 time)
|
1982 Cell-mediated cytotoxicity by peripheral blood lymphocytes against basic protein of myelin, encephalitogenic peptide, cerebrosides and gangliosides in multiple sclerosis.
|
| 38 |
organic nitrogen detector
(1 time)
|
Environmental Health
(1 time)
|
LC-OCD-OND (1 time)
SEC-OCD (1 time)
|
2010 Characterisation of aquatic humic and non-humic matter with size-exclusion chromatography--organic carbon detection--organic nitrogen detection (LC-OCD-OND).
|
| 39 |
originally nondeprived
(1 time)
|
Neurology
(1 time)
|
LGN (1 time)
OD (1 time)
|
1998 Morphology of single geniculocortical afferents and functional recovery of the visual cortex after reverse monocular deprivation in the kitten.
|
| 40 |
orthographic neighborhood density
(1 time)
|
Brain
(1 time)
|
PND (1 time)
|
2017 Interactions in the neighborhood: Effects of orthographic and phonological neighbors on N400 amplitude.
|
| 41 |
other CNS diseases
(1 time)
|
Neurology
(1 time)
|
aCL (1 time)
IgG (1 time)
IgM (1 time)
|
1998 Specificity, isotype, and titer distribution of anticardiolipin antibodies in CNS diseases.
|
| 42 |
other disease controls
(1 time)
|
Allergy and Immunology
(1 time)
|
BADGE (1 time)
CSF (1 time)
HAM/TSP (1 time)
|
2006 Genetic variability in the extracellular matrix protein as a determinant of risk for developing HTLV-I-associated neurological disease.
|
| 43 |
other nervous diseases
(1 time)
|
Medicine
(1 time)
|
Anti-MBP (1 time)
CMP (1 time)
CVD (1 time)
|
1995 [Enzyme-linked immunoadsorbent assays for myelin basic protein and antibodies to myelin basic protein in serum and CSF of patients with diseases of the nervous system].
|
| 44 |
other nervous system disorders
(1 time)
|
Neurology
(1 time)
|
AGE (1 time)
CSF (1 time)
IEF (1 time)
|
2000 Oligoclonal bands in cerebrospinal fluid: a comparative study of isoelectric focusing, agarose gel electrophoresis and IgG index.
|
| 45 |
other neurodegenerative diseases
(1 time)
|
Neurology
(1 time)
|
CCD (1 time)
CCSVI (1 time)
MS (1 time)
|
2013 Italian multicentre observational study of the prevalence of CCSVI in multiple sclerosis (CoSMo study): rationale, design, and methodology.
|
| 46 |
other neurologic disease controls
(1 time)
|
Neurology
(1 time)
|
ADEM (1 time)
EDSS (1 time)
GFAP (1 time)
|
2010 Astrocytic damage is far more severe than demyelination in NMO: a clinical CSF biomarker study.
|
| 47 |
other neurological diseases without dementia
(1 time)
|
Geriatrics
(1 time)
|
Abeta1-42 (1 time)
CSF (1 time)
MCI (1 time)
|
2012 Performance of abeta1-40, abeta1-42, total tau, and phosphorylated tau as predictors of dementia in a cohort of patients with mild cognitive impairment.
|
| 48 |
other neurological disorders without cognitive impairment
(1 time)
|
Neurology
(1 time)
|
Abeta1-42 (1 time)
CSF (1 time)
OD (1 time)
|
2009 Abeta1-42 Detection in CSF of Alzheimer's disease is influenced by temperature: indication of reversible Abeta1-42 aggregation?
|
| 49 |
other neurological noninflammatory and non-neurodegenerative diseases
(1 time)
|
Alzheimer Disease
(1 time)
|
AD (1 time)
AUC (1 time)
CI (1 time)
|
2018 A new enzyme-linked immunosorbent assay for neurofilament light in cerebrospinal fluid: analytical validation and clinical evaluation.
|
| 50 |
other neuropsychiatric disorders
(1 time)
|
Acquired Immunodeficiency Syndrome
(1 time)
|
CI (1 time)
CPM (1 time)
NPD (1 time)
|
2006 Neuropsychiatric disorders in HIV infection: impact of diagnosis on economic costs of care.
|
| 51 |
other non-psychotic disorders
(1 time)
|
Psychiatry
(1 time)
|
AD (1 time)
|
2006 Adolescent adjustment disorder: precipitant stressors and distress symptoms of 89 outpatients.
|
| 52 |
other than ASD
(1 time)
|
Environmental Health
(1 time)
|
ASD (1 time)
|
2022 Peripheral Iron Levels in Autism Spectrum Disorders vs. Other Neurodevelopmental Disorders: Preliminary Data.
|
A Search Service for Abbreviation / Long Form